琥乙红霉素结构式
|
常用名 | 琥乙红霉素 | 英文名 | Erythromycin Ethylsuccinate |
|---|---|---|---|---|
| CAS号 | 1264-62-6 | 分子量 | 862.053 | |
| 密度 | 1.2±0.1 g/cm3 | 沸点 | 874.1±65.0 °C at 760 mmHg | |
| 分子式 | C43H75NO16 | 熔点 | 219-224ºC | |
| MSDS | 中文版 美版 | 闪点 | 482.4±34.3 °C | |
| 符号 |
GHS08 |
信号词 | Danger |
琥乙红霉素用途Erythromycin乙基琥珀酸盐是一种抗生素,用于治疗多种细菌感染,具有与青霉素类似或稍宽于青霉素的抗菌谱。 |
| 中文名 | 磺胺噻唑 |
|---|---|
| 英文名 | Erythromycin ethyl succinate |
| 中文别名 | 琥乙红霉素 |
| 英文别名 | 更多 |
| 密度 | 1.2±0.1 g/cm3 |
|---|---|
| 沸点 | 874.1±65.0 °C at 760 mmHg |
| 熔点 | 219-224ºC |
| 分子式 | C43H75NO16 |
| 分子量 | 862.053 |
| 闪点 | 482.4±34.3 °C |
| 精确质量 | 861.508606 |
| PSA | 226.28000 |
| LogP | 4.10 |
| InChIKey | NSYZCCDSJNWWJL-NLATUGTHSA-N |
| SMILES | CCOC(=O)CCC(=O)OC1C(OC2C(C)C(OC3CC(C)(OC)C(O)C(C)O3)C(C)C(=O)OC(CC)C(C)(O)C(O)C(C)C(=O)C(C)CC2(C)O)OC(C)CC1N(C)C |
| 外观性状 | 白色至淡黄色结晶固体 |
| 蒸汽压 | 0.0±0.6 mmHg at 25°C |
| 折射率 | 1.529 |
| 储存条件 | 2-8°C |
| 水溶解性 | ethanol: soluble50mg/mL | Freely soluble in organic solvents, practically insoluble in water |
| 符号 |
GHS08 |
|---|---|
| 信号词 | Danger |
| 危害声明 | H317-H334 |
| 警示性声明 | P261-P280-P284-P304 + P340-P342 + P311 |
| 个人防护装备 | dust mask type N95 (US);Eyeshields;Faceshields;Gloves |
| 危害码 (欧洲) | Xn:Harmful |
| 风险声明 (欧洲) | R42/43 |
| 安全声明 (欧洲) | S36 |
| 危险品运输编码 | NONH for all modes of transport |
| WGK德国 | 2 |
| RTECS号 | WM9800000 |
| 海关编码 | 2941500000 |
|
~%
琥乙红霉素 1264-62-6 |
| 文献:Antibiotics Chemotherapy, , vol. 7, p. 487 |
| 琥乙红霉素上游产品 2 | |
|---|---|
| 琥乙红霉素下游产品 0 | |
| 海关编码 | 2941500000 |
|---|
|
Hapten synthesis, monoclonal antibody production and development of a competitive indirect enzyme-linked immunosorbent assay for erythromycin in milk.
Food Chem. 171 , 98-107, (2014) Erythromycin is an antibiotic used extensively in veterinary practice worldwide for treatment, prevention and growth promotion. In this work, monoclonal antibodies (Mabs) against erythromycin were pro... |
|
|
Sensitive determination of tilmicosin, erythromycin ethylsuccinate and clindamycin by CE with electrochemiluminescence detection using azithromycin as internal standard and its applications.
J. Sep. Sci. 33(9) , 1305-11, (2010) A sensitive approach for the simultaneous determination of tilmicosin, erythromycin ethylsuccinate and clindamycin was developed by CE coupled with electrochemiluminescence detection with ionic liquid... |
|
|
Pharmacokinetics of erythromycin after the administration of intravenous and various oral dosage forms to dogs.
J. Vet. Pharmacol. Ther. 31(6) , 496-500, (2008) The purpose of this study was to describe and compare the pharmacokinetic properties of different formulations of erythromycin in dogs. Erythromycin was administered as lactobionate (10 mg/kg, IV), es... |
| ERYTHROMYCIN ETHYISUCCINATE |
| ERYTHROCINETHYLSUCCINATE |
| ErythromycinEthylsuccinate |
| Erythromycin ethylsuccinate |
| ERYTHROMYCIN ETHYL SUCCINATE |
| ERYTHROMYCIN ETHYLSUCCINATE API |
| (2S,3R,4S,6R)-4-(Dimethylamino)-2-{[(3S,4R,5R,6S,7S,9S,11S,12S,13R,14S)-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyl-2,10-dioxooxacyclotetradecan-6-yl]oxy}-6-methyltetrahydro-2H-pyran-3-yl ethyl succinate |
| ERYTHROMYCIN ETHYLSUCCINATE, ANTIBIOTIC FOR CULTURE MEDIA USE ONLY |